Purchase Order 75N92024P00303
Award Date 9/10/24
Potential Completion Date 11/15/24
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, has awarded a $171,374 firm fixed price purchase order to Lovelace Biomedical Research Institute. Under this contract, Lovelace will conduct an evaluation of an angiotensin-converting enzyme inhibitor in a mouse model combining cigarette smoke exposure and influenza infection. All work will be performed by Lovelace in Albuquerque, New Mexico over a one-year...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
- This federal contract award, valued at $1,013,722.26, was issued by the National Heart Lung and Blood Institute, a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The award is for the GTRP Pharmacology-Toxicology Core Lab, Task Order 6, Task Area B, with a period of performance through April 15, 2017. The contract is a cost-plus-fixed-fee delivery order, without a set-aside designation. LBERI, a...
- This firm fixed price delivery order for $24,990 was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute. The order was issued against the GSA Schedule for Professional and Allied Healthcare Staffing Services and requires a mouse study of smoking to further the research aims of the Levy Lab at NIH/NHBLI/PSB regarding developing therapeutic targets. The study is to be completed by...
- This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Heart Lung and Blood Institute (NHLBI). The $1,609,194.07 contract is a Delivery Order under the Gene Therapy Resource Program (GTRP) to provide pharmacology/toxicology core laboratory services for a scientific project. This work supports the National Institutes of Health's research efforts in gene therapy. The contract does not have a set-aside...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $625,343.90 contract is for the PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT under the Gene Therapy Resource Program (GTRP). Lovelace will provide a range of preclinical research services to support the...
- This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
- This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The $211,128.00 contract is for respiratory interaction studies in rodents to assess the ability of a test article to reverse the respiratory depressant effects of opioids. The work supports NIDA's mission to advance potential treatments for drug-induced...
- This is a $385,704.00 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the characterization of spontaneous osteogenesis, or bone formation, after surgical segmental bone defect in a large animal model. The work will take place in...